Antiretroviral adherence program in HIV patients: A feasibility study in the Swiss HIV Cohort Study

Pharmacy World and Science

Volumn 32, Issue 6, 2010, Pages 776-786

  Krummenacher, Isabelle ^a   Cavassini, Matthias ^b   Bugnon, Olivier ^a   Spirig, Rebecca ^c   Schneider, Marie P ^a,d  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITY OF BASEL   (Switzerland)

^d POLICLINIQUE MÉDICALE UNIVERSITAIRE   (Switzerland)

Author keywords

Antiretroviral therapy; Electronic drug monitoring; Feasibility studies; HIV; Intervention; Medication adherence; Motivational interviewing; Pharmacists; Switzerland

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; ATTITUDE TO HEALTH; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; COHORT ANALYSIS; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG MONITORING; FEASIBILITY STUDY; FEMALE; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERDISCIPLINARY COMMUNICATION; INTERVENTION STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRIMARY HEALTH CARE; SOCIAL SUPPORT; SWITZERLAND; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PILOT PROJECTS; SWITZERLAND;

EID: 78650227555     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-010-9437-2     Document Type: Article

References (41)

1. Bangsberg DR, Perry S, Charlebois ED, Clark RA, Roberston M, Zolopa AR, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15:1181-3. (Pubitemid 32549871)
2. Bangsberg DR. Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis. 2006;43:939-41. (Pubitemid 44435526)
3. Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333:15.
4. Glass TR, de Geest S, Weber R, Vernazza PL, Rickenbach M, Furrer H, et al. Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study. J Acquir Immune Defic Syndr. 2006;41:385-92.
5. World Health Organization. Adherence to long-term therapies. Evidence for action. (2003). ISBN 9789241545990, 9241545992
6. Liu H, Golin CE, Miller LG, Hays RD, Beck CK, Sanandaji S, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001;134:968-77. (Pubitemid 32466236)
7. Rosen MI, Dieckhaus K, McMahon TJ, Valdes B, Petry NM, Cramer J, et al. Improved adherence with contingency management. AIDS Patient Care STDS. 2007;21:30-40.
8. Matsuyama JR, Mason BJ, Jue SG. Pharmacists' interventions using an electronic medication-event monitoring device's adherence data versus pill counts. Ann Pharmacother. 1993;27:851-5. (Pubitemid 23225667)
9. Ammassari A, Murri R, Pezzotti P, Trotta MP, Ravasio L, De Longis P, et al. Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. J Acquir Immune Defic Syndr. 2001;28:445-9. (Pubitemid 34033195)
10. Spirig R, Moody K, Battegay M, de Geest S. Symptom management in HIV/AIDS: advancing the conceptualization. ANS Adv Nurs Sci. 2005;28:333-44.
11. Vogl D, Rosenfeld B, Breitbart W, Thaler H, Passik S, McDonald M, et al. Symptom prevalence, characteristics, and distress in AIDS outpatients. J Pain Symptom Manage. 1999;18:253-62. (Pubitemid 29469703)
12. Wilson HS, Hutchinson SA, Holzemer WL. Reconciling incompatibilities: a grounded theory of HIV medication adherence and symptom management. Qual Health Res. 2002;12:1309-22.
13. Simoni JM, Pearson CR, Pantalone DW, Marks G, Crepaz N. Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load: a meta-analytic review of randomized controlled trials. J Acquir Immune Defic Syndr. 2006;43:S23-35.
14. Swiss HIV Cohort Study. The Swiss HIV Cohort Study. https://www.shcs.ch (2010). Updated 2 Feb 2210; cited 27 Apr 2010.
15. Miller WR, Rollnick S, Conforti K. Motivational interviewing: preparing people for change. 2nd ed. New York: The Guilford Press; 2002. ISBN 1572305630, 978-1572305632.
16. Cooperman NA, Arnsten JH. Motivational interviewing for improving adherence to antiretroviral medications. Curr HIV/AIDS Rep. 2005;2:159-64.
17. Fisher JD, Fisher WA, Amico KR, Harman JJ. An informationmotivation- behavioral skills model of adherence to antiretroviral therapy. Health Psychol. 2006;25:462-73. (Pubitemid 44167248)
18. Fisher JD, Amico KR, Fisher WA, Harman JJ. The informationmotivation- behavioral skills model of antiretroviral adherence and its applications. Curr HIV/AIDS Rep. 2008;5:193-203.
19. Bandura A. Health functioning. In: Bandura A, editor. Self-efficacy, the exercise of control. New York: W.H. Freeman and Co; 1997. p. 259-318. ISBN 0716728508, 978-0716728504.
20. Munro SA, Lewin SA, Swart T, Volmink J. A review of health behaviour theories: how useful are these for developing interventions to promote long-term medication adherence for TB and HIV/AIDS? BMC Public Health. 2007;7:104.
21. Glass TR, de Geest S, Hirschel B, Battegay M, Furrer H, Cavassini M, et al. Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients. Antivir Ther. 2008;13:77-85. (Pubitemid 351541676)
22. Bakken S, Holzemer WL, Brown MA, Powell-Cope GM, Turner JG, Inouye J, et al. Relationships between perception of engagement with health care provider and demographic characteristics, health status, and adherence to therapeutic regimen in persons with HIV/AIDS. AIDS Patient Care STDS. 2000;14:189-97. (Pubitemid 30225313)
23. Fleury J, Cameron K. The index of readiness. In: Strickland OL, Dilorio C, editors. Measurement of Nursing Outcomes. 2nd ed. New York: Springer Publishing Company; 2003. p. 265-75. ISBN 0826117953, 978082611795.
24. Norbeck JS, Lindsey AM, Carrieri VL. The development of an instrument to measure social support. Nurs Res. 1981;30:264-9.
25. Wu AW, Rubin HR, Mathews WC, Ware JE Jr, Brysk LT, Hardy WD, et al. A health status questionnaire using 30 items from the Medical Outcomes Study. Preliminary validation in persons with early HIV infection. Med Care. 1991;29:786-98.
26. Brown RL, Rounds LA. Conjoint screening questionnaires for alcohol and other drug abuse: criterion validity in a primary care practice. Wis Med J. 1995;94:135-40.
27. De Geest S, Abraham I, Gemoets H, Evers G. Development of the long-term medication behaviour self-efficacy scale: qualitative study for item development. J Adv Nurs. 1994;19:233-8.
28. Lepine JP. L'échelle HAD (hospital anxiety and depression scale). In: Guelfi JD, editor. Évaluation clinique standardisée en psychiatrie, tome II. Éditions médicales Pierre-Fabre ed. 1997. p. 367-72. ISBN 2867870828.
29. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361-70. (Pubitemid 13098606)
30. Vincenzi CB, Moody K, Spirig R. Development and pretesting of a set of symptom assessment tools in HIV: the HIV symptom experience assessment scale and the HIV symptom manageability scale. Appl Nurs Res. 2009;22:204-10.
31. Vrijens B, Goetghebeur E. Comparing compliance patterns between randomized treatments. Control Clin Trials. 1997;18:187-203. (Pubitemid 27277906)
32. Diiorio C, McCarty F, Resnicow K, McDonnell HM, Soet J, Yeager K, et al. Using motivational interviewing to promote adherence to antiretroviral medications: a randomized controlled study. AIDS Care. 2008;20:273-83. (Pubitemid 351451238)
33. Catz SL, Kelly JA, Bogart LM, Benotsch EG, McAuliffe TL. Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol. 2000;19:124-33.
34. Gordillo V, del AJ, Soriano V, Gonzalez-Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS. 1999;13:1763-9. (Pubitemid 30015725)
35. Roberts KJ. Barriers to and facilitators of HIV-positive patients' adherence to antiretroviral treatment regimens. AIDS Patient Care STDS. 2000;14:155-68. (Pubitemid 30185387)
36. Simoni JM, Frick PA, Huang B. A longitudinal evaluation of a social support model of medication adherence among HIV-positive men and women on antiretroviral therapy. Health Psychol. 2006;25:74-81. (Pubitemid 43214384)
37. Levine AJ, Hinkin CH, Castellon SA, Mason KI, Lam MN, Perkins A, et al. Variations in patterns of highly active antiretroviral therapy (HAART) adherence. AIDS Behav. 2005;9:355-62. (Pubitemid 41584987)
38. Deschamps AE, Graeve VD, van Wijngaerden E, De Saar V, Vandamme AM, van Varenbergh K, et al. Prevalence and correlates of nonadherence to antiretroviral therapy in a population of HIV patients using medication event monitoring system. AIDS Patient Care STDS. 2004;18:644-57. (Pubitemid 39579158)
39. Burnier M, Schneider MP, Chiolero A, Stubi CL, Brunner HR. Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions. J Hypertens. 2001;19:335-41. (Pubitemid 32116286)
40. Cramer J, Rosenheck R, Kirk G, Krol W, Krystal J. Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes. Value Health. 2003;6:566-73. (Pubitemid 37187719)
41. De Geest S, Schafer-Keller P, Denhaerynck K, Thannberger N, Kofer S, Bock A, et al. Supporting medication adherence in renal transplantation (SMART): a pilot RCT to improve adherence to immunosuppressive regimens. Clin Transplant. 2006;20:359-68. (Pubitemid 43880573)